Want to see TSE:OPTI full AI Analyst Report?
OPTI Stock Chart & Stats
C$6.83
C$0.09(1.35%)
At close: 4:00 PM EDT
C$6.83
C$0.09(1.35%)
Day’s Range― - ―
52-Week RangeC$4.35 - C$12.15
Previous CloseN/A
Volume8.12K
Average Volume (3M)4.55K
Market Cap
C$25.77M
Enterprise ValueC$23.87M
Total Cash (Recent Filing)C$13.07M
Total Debt (Recent Filing)C$5.14M
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Feb 02, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.95
Shares Outstanding5,725,867
10 Day Avg. Volume4,394
30 Day Avg. Volume4,547
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)5.70
Price to Sales (P/S)87.81
P/FCF Ratio-13.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.64
Revenue Forecast (FY)C$1.22M
Bulls Say, Bears Say
Bulls Say
Equity CushionThe reported equity base provides some balance-sheet cushioning relative to total assets, giving Optimi a foundation from which to pursue operations. This does not remove funding pressure, but it indicates the company is not currently described as balance-sheet distressed on asset and equity size.
Integrated Mushroom OperationsOptimi operates across multiple stages of the mushroom-related value chain, including cultivation, processing, manufacturing, and product supply. That breadth creates several potential routes to commercial activity and allows the company to participate in both functional mushroom and psychedelic research markets.
Earlier Revenue ExpansionMaterial revenue growth across the earlier 2022–2025 period shows that Optimi has demonstrated some ability to expand its commercial activity over time. Although the latest trend has weakened, this prior progression provides evidence of an established route to revenue generation rather than a wholly untested model.
Bears Say
Persistent UnprofitabilityDeeply negative gross and EBITDA margins, together with a large trailing loss, indicate that current revenue is not covering the cost of operations. Persistent unprofitability limits internally generated funding, weakens capital efficiency, and makes a durable earnings recovery dependent on substantial operating improvement.
Continued Cash BurnOperating and free cash flow remain materially negative, showing that the reported losses are translating into actual cash consumption rather than being mainly accounting effects. If this burn persists, Optimi may have less flexibility to fund growth and greater dependence on external financing.
Revenue Contraction And Scale PressureThe latest revenue decline, combined with a very small trailing revenue base, points to limited operating scale and an uncertain near-term path toward efficiency. Lower sales reduce the opportunity to absorb fixed costs, making margin recovery and sustainable profitability more difficult over the next several quarters.
Optimi Health News
OPTI FAQ
What was Optimi Health’s price range in the past 12 months?
Optimi Health lowest stock price was C$4.35 and its highest was C$12.15 in the past 12 months.
What is Optimi Health’s market cap?
Optimi Health’s market cap is C$25.77M.
When is Optimi Health’s upcoming earnings report date?
Optimi Health’s upcoming earnings report date is Feb 02, 2027 which is in 101 days.
How were Optimi Health’s earnings last quarter?
Optimi Health released its earnings results on Aug 14, 2026. The company reported -C$0.56 earnings per share for the quarter, missing the consensus estimate of -C$0.4 by -C$0.16.
Is Optimi Health overvalued?
According to Wall Street analysts Optimi Health’s price is currently Overvalued.
Does Optimi Health pay dividends?
Optimi Health does not currently pay dividends.
What is Optimi Health’s EPS estimate?
Optimi Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Optimi Health have?
Optimi Health has 5,725,867 shares outstanding.
What happened to Optimi Health’s price movement after its last earnings report?
Optimi Health reported an EPS of -C$0.56 in its last earnings report, missing expectations of -C$0.4. Following the earnings report the stock price went down -0.752%.
Which hedge fund is a major shareholder of Optimi Health?
Currently, no hedge funds are holding shares in TSE:OPTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Optimi Health
Optimi Health Corp. focuses on developing an integrated brand of functional mushrooms specifically for the Canadian health and wellness food markets. The company manages the entire process from the cultivation and extraction to the processing and distribution of these mushroom strains. Among the fungi varieties it offers are Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. Incorporated in 2020, the company was initially known as 1251418 BC Ltd. before officially changing its name to Optimi Health Corp. in August of that year. Its operations are headquartered in Vancouver, Canada.
Technical Analysis
Rapid Dose Therapeutics Corp
―
MediPharm Labs
―
PharmaCielo
―
Rubicon Organics
―
Avicanna
―